BDBM740261 N-((1S)-1-cyclohexyl- 2-((2-(5,5-dimethyl-2- oxotetrahydropyrimidin- 1(2H)-yl)-2- (methylcarbamoyl)-2,3- dihydro-1H-inden-5- yl)amino)-2-oxoethyl)- 1-methyl-1H-pyrazole- 5-carboxamide::US20250154138, Example 70

SMILES CNC(=O)C1(N2CC(C)(C)CNC2=O)Cc2ccc(NC(=O)[C@@H](NC(=O)c3ccnn3C)C3CCCCC3)cc2C1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 740261   

TargetInterleukin-17 receptor A/(Human)
Beigene

US Patent
LigandPNGBDBM740261(N-((1S)-1-cyclohexyl- 2-((2-(5,5-dimethyl-2- oxote...)
Affinity DataIC50: 26nMAssay Description:Compounds disclosed herein were tested for blocking of human IL-17A (Cat: C774, novoprotein) protein with its receptor human IL-17RA (Cat: C153, novo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/15/2025
Entry Details
US Patent